Breaking News

Kendle Acquires Latin American CRO

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Kendle has entered into agreements to acquire Latin America CRO, International Clinical Research Ltd. and related companies, adding to its global clinical development capabilities in the Phase II-IV arena through new operations in Argentina, Brazil, Colombia and Chile. The move supports the company’s strategic business expansion in high-growth regions to deliver global trials for its biopharmaceutical customers, and builds on existing capabilities in Mexico and Peru. The acquisition is the...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters